Columbus Circle Investors’s Agios Pharmaceuticals AGIO Stock Holding History

Columbus Circle Investors’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,837	Closed	-$857K	–	179
2017 Q3	$857K	Sell	12,837 -4,803	-27%	-$288K	0.01%	270
2017 Q2	$908K	Sell	17,640 -25,240	-59%	-$1.29M	0.02%	229
2017 Q1	$2.5M	Sell	42,880 -189,755	-82%	-$9.1M	0.04%	215
2016 Q4	$9.71M	Sell	232,635 -70,254	-23%	-$3.69M	0.13%	148
2016 Q3	$16M	Buy	+302,889	New	+$13.2M	0.17%	114
2015 Q1	–	Sell	-122,547	Closed	-$13.7M	–	283
2014 Q4	$13.7M	Buy	122,547 +42,233	+53%	+$3.77M	0.1%	180
2014 Q3	$4.93M	Buy	+80,314	New	+$3.46M	0.04%	211

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Columbus Circle Investors's AGIO Position: Q4 2017 in Review

Columbus Circle Investors sold out of Agios Pharmaceuticals (AGIO) in Q4 2017, closing a stake of 12,837 shares — an estimated $857K sold.

Columbus Circle Investors first reported a position in AGIO in Q3 2014 and held it in 7 quarters. The position peaked at $16M in Q3 2016. 178 funds tracked by Wall St. Rank hold AGIO as of Q4 2017.

Columbus Circle Investors reported no remaining Agios Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
Columbus Circle Investors sold 12,837 Agios Pharmaceuticals shares in Q4 2017, an estimated $857K.
Columbus Circle Investors first reported a position in Agios Pharmaceuticals in Q3 2014 and held it in 7 quarters.
Columbus Circle Investors's Agios Pharmaceuticals position peaked at $16M in Q3 2016.
178 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2017.

Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.